AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29

Authors: Kaul, N Devaraj, S Jialal, I
Citation: N. Kaul et al., alpha-Tocopherol and Atherosclerosis, EXP BIOL ME, 226(1), 2001, pp. 5-12

Authors: Yang, TTC Devaraj, S Jialal, I
Citation: Ttc. Yang et al., Oxidative stress and atherosclerosis, J CLIN LIG, 24(1), 2001, pp. 13-24

Authors: Jialal, I Traber, M Devaraj, S
Citation: I. Jialal et al., Is there a vitamin E paradox?, CURR OP LIP, 12(1), 2001, pp. 49-53

Authors: Feldman, M Jialal, I Devaraj, S Cryer, B
Citation: M. Feldman et al., Effects of low-dose aspirin on serum C-reactive protein and thromboxane B-2 concentrations: A placebo-controlled study using a highly sensitive C-reactive protein assay, J AM COL C, 37(8), 2001, pp. 2036-2041

Authors: Devaraj, S Hollingworth, DG Schroeder, RG
Citation: S. Devaraj et al., Generic manufacturing strategies: an empirical test of two configurationaltypologies, J OPER MANA, 19(4), 2001, pp. 427-452

Authors: O'Byrne, D Devaraj, S Islam, KN Collazo, R McDonald, L Grundy, S Jialal, I
Citation: D. O'Byrne et al., Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy, METABOLISM, 50(2), 2001, pp. 207-215

Authors: Conlon, E Devaraj, S Matta, KF
Citation: E. Conlon et al., The relationship between initial quality perceptions and maintenance behavior: The case of the automotive industry, MANAG SCI, 47(9), 2001, pp. 1191-1202

Authors: Jialal, I Devaraj, S Kaul, N
Citation: I. Jialal et al., The effect of alpha-tocopherol on monocyte proatherogenic activity, J NUTR, 131(2), 2001, pp. 389S-394S

Authors: Devaraj, S Hugou, I Jialal, I
Citation: S. Devaraj et al., alpha-Tocopherol decreases CD36 expression in human monocyte-derived macrophages, J LIPID RES, 42(4), 2001, pp. 521-527

Authors: Ahire, SL Devaraj, S
Citation: Sl. Ahire et S. Devaraj, An empirical comparison of statistical construct validation approaches, IEEE MANAGE, 48(3), 2001, pp. 319-329

Authors: Devaraj, S Hirany, SV Burk, RF Jialal, I
Citation: S. Devaraj et al., Divergence between LDL oxidative susceptibility and urinary F-2-isoprostanes as measures of oxidative stress in type 2 diabetes, CLIN CHEM, 47(11), 2001, pp. 1974-1979

Authors: Jialal, I Stein, D Balis, D Grundy, SM Adams-Huet, B Devaraj, S
Citation: I. Jialal et al., Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy onhigh sensitive C-reactive protein levels, CIRCULATION, 103(15), 2001, pp. 1933-1935

Authors: Meira, LB Devaraj, S Kisby, GE Burns, DK Daniel, RL Hammer, RE Grundy, S Jialal, I Friedberg, EC
Citation: Lb. Meira et al., Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress, CANCER RES, 61(14), 2001, pp. 5552-5557

Authors: Kaul, N Devaraj, S Grundy, SM Jialal, I
Citation: N. Kaul et al., Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects, AM J CARD, 87(11), 2001, pp. 1320-1323

Authors: Devaraj, S Jialal, I
Citation: S. Devaraj et I. Jialal, Oxidative stress and antioxidants in type 2 diabetes, NUTR HLTH, 2001, pp. 117-125

Authors: O'Byrne, D Grundy, S Packer, L Devaraj, S Baldenius, K Hoppe, PP Kraemer, K Jialal, I Traber, MG
Citation: D. O'Byrne et al., Studies of LDL oxidation following alpha-, gamma-, or delta-tocotrienyl acetate supplementation of hypercholesterolemic humans, FREE RAD B, 29(9), 2000, pp. 834-845

Authors: Devaraj, S Jialal, I
Citation: S. Devaraj et I. Jialal, Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and Type 2 diabetic patients, FREE RAD B, 29(8), 2000, pp. 790-792

Authors: Devaraj, S Kohli, R
Citation: S. Devaraj et R. Kohli, Information technology payoff in the health-care industry: A longitudinal study, J MANAG I S, 16(4), 2000, pp. 41-67

Authors: Jialal, I Devaraj, S
Citation: I. Jialal et S. Devaraj, Vitamin E supplementation and cardiovascular events in high-risk patients., N ENG J MED, 342(25), 2000, pp. 1917-1917

Authors: Islam, KN O'Byrne, D Devaraj, S Palmer, B Grundy, SM Jialal, I
Citation: Kn. Islam et al., Alpha-tocopherol supplementation decreases the oxidative susceptibility ofLDL in renal failure patients on dialysis therapy, ATHEROSCLER, 150(1), 2000, pp. 217-224

Authors: Hirany, S O'Byrne, D Devaraj, S Jialal, I
Citation: S. Hirany et al., Remnant-like particle-cholesterol concentrations in patients with type 2 diabetes mellitus and end-stage renal disease, CLIN CHEM, 46(5), 2000, pp. 667-672

Authors: Devaraj, S Jialal, I
Citation: S. Devaraj et I. Jialal, Low-density lipoprotein postsecretory modification, monocyte function, andcirculating adhesion molecules in type 2 diabetic patients with and without macrovascular complications - The effect of alpha-tocopherol supplementation, CIRCULATION, 102(2), 2000, pp. 191-196

Authors: Devaraj, S Hirany, S Jialal, I
Citation: S. Devaraj et al., Ratio of remnant-like particle cholesterol to serum total triglycerides isa reliable screening test for type III dyslipidaemia, ANN CLIN BI, 37, 2000, pp. 790-791

Authors: Marangon, K O'Byrne, D Devaraj, S Jialal, I
Citation: K. Marangon et al., Validation of an immunoassay for measurement of plasma total homocysteine, AM J CLIN P, 112(6), 1999, pp. 757-762

Authors: Devaraj, S Jialal, I
Citation: S. Devaraj et I. Jialal, alpha-tocopherol decreases interleukin-1 beta release from activated humanmonocytes by inhibition of 5-lipoxygenase, ART THROM V, 19(4), 1999, pp. 1125-1133
Risultati: 1-25 | 26-29